MARSHALL WACE, LLP

Position in SIBN — SI-BONE, Inc.

CIK 1318757 LONDON, X0

Position in SIBN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$11,265,497

+$9,142,041 QoQ

Shares Held

690,288

+310.6% QoQ

Ownership

1.54%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#20

of 168 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. SIBN ranks #12 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	5,542,438	$502,920,823
2	BSX	Boston Scientific Corp	2,414,223	$103,039,037
3	GKOS	GLAUKOS Corp	314,804	$43,997,006
4	DXCM	Dexcom Inc	532,804	$35,884,349
5	EW	Edwards Lifesciences Corp	344,361	$31,150,895
6	PEN	Penumbra Inc	90,520	$28,581,689
7	SYK	Stryker Corp	51,116	$16,093,361
8	GMED	Globus Medical Inc	188,541	$14,896,623

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,265,497	690,288	+310.6%	Shares	Other	2026-08-13
2026-03-31	$2,123,456	168,128	-49.9%	Shares	Other	2026-05-15
2025-12-31	$6,623,493	335,877	+74.7%	Shares	Other	2026-02-13
2025-09-30	$2,830,361	192,280	-55.9%	Shares	Other	2025-11-13
2025-06-30	$8,209,527	436,213	+18.2%	Shares	Other	2025-08-13
2025-03-31	$5,177,223	369,011	+39.5%	Shares	Other	2025-05-15
2024-12-31	$3,708,610	264,523	+332.5%	Shares	Other	2025-02-13
2024-09-30	$855,044	61,162	-70.7%	Shares	Other	2024-11-14
2024-06-30	$2,698,309	208,686	+49.9%	Shares	Other	2024-08-14
2024-03-31	$2,279,702	139,261	-56.5%	Shares	Other	2024-05-15
2023-12-31	$6,727,420	320,506	-28.9%	Shares	Other	2024-02-14
2023-09-30	$9,569,448	450,539	-20.3%	Shares	Other	2023-11-14
2023-06-30	$15,254,195	565,389	+7842.0%	Shares	Other	2023-08-14
2021-03-31	$226,455	7,119	-81.2%	Shares	Sole	2021-05-17
2020-12-31	$1,132,372	37,872	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.